Transfusion · 2006 · 23 citations · 11 references
MedicineGeneticsMolecular GeneticsGene Expression AnalysisImmunogeneticsMedical GeneticsBlood Group SerologyHemolytic DisordersHistocompatibilityHistocompatibility AntigensPrenatal Molecular TestingRed Blood Cell DisordersBlood Group PolymorphismsErythrocyte Membrane GlycoproteinsMolecular GenotypingNeonatal Hemolytic DiseaseRed Blood Cell Antigen ExpressionRed Cell GenotypingTransversion MutationsUnrelated Donation
BACKGROUND: The KEL2/KEL1 (k/K) blood group polymorphism represents 578C>T in the KEL gene and Thr193Met in the Kell glycoprotein. Anti-KEL1 can cause severe hemolytic disease of the fetus and newborn. Molecular genotyping for KEL*1 is routinely used for assessing whether a fetus is at risk. Red blood cells (RBCs) from a KEL:1 blood donor (D1) were found to have abnormal KEL1 expression during evaluation of anti-KEL1 reagents. STUDY DESIGN AND METHODS: Kell genotyping methods, including KEL exon 6 direct sequencing, were applied. KEL cDNA from D1 was sequenced. Flow cytometry was used to assess KEL1 and KEL2 RBC expression. RESULTS: RBCs from the donor, her mother, and an unrelated donor gave weak or negative reactions with some anti-KEL1 reagents. Other Kell-system antigens appeared normal. The three individuals were homozygous for KEL C578 (KEL*2) but heterozygous for a 577A>T transversion, encoding Ser193. They appeared to be KEL*2 homozygotes by routine genotyping methods. Flow cytometry revealed weak KEL1 expression and normal KEL2, similar to that of KEL*2 homozygotes. CONCLUSION: Ser193 in the Kell glycoprotein appears to result in expression of abnormal KEL1, in addition to KEL2. The mutation is not detected by routine Kell genotyping methods and, because of unpredicted KEL1 expression, could lead to a misdiagnosis.
11
Report of the Third International Workshop on Molecular Blood Group Genotyping
Geoff Daniels, C. Ellen van der Schoot, Christoph Gassner et al. · Vox Sanguinis · 2009 · 82 citations
Medicine, Genetics, Hematology +13
Identification of a Defect in the Intracellular Trafficking of a Kell Blood Group Variant
Karina Yazdanbakhsh, Soohee Lee, Qian Yu et al. · Blood · 1999 · 49 citations